Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
18.56
+0.17 (+0.92%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,133,296
Open
18.47
Bid (Size)
18.36 (1)
Ask (Size)
18.58 (30)
Prev. Close
18.39
Today's Range
18.27 - 18.57
52wk Range
8.055 - 18.58
Shares Outstanding
1,110,352,397
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
August 23, 2024
Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite concerns, experts predict limited financial impact on companies like Pfizer,...
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today
August 21, 2024
Via
Benzinga
Performance
YTD
+73.95%
+73.95%
1 Month
+10.48%
+10.48%
3 Month
+10.74%
+10.74%
6 Month
+39.65%
+39.65%
1 Year
+91.34%
+91.34%
More News
Read More
Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
August 20, 2024
Via
Investor's Business Daily
$100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
August 13, 2024
Via
Benzinga
The 7 Best Under $20 Stocks to Buy in August 2024
August 07, 2024
Via
InvestorPlace
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
July 29, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
July 19, 2024
Via
Benzinga
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
August 06, 2024
Via
PressReach
Exposures
Product Safety
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
August 02, 2024
Via
InvestorPlace
Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA And Other Big Stocks Moving Higher On Wednesday
July 31, 2024
Via
Benzinga
Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
July 31, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript
July 31, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Teva Beats Q2 Estimates, Raises Annual Outlook On Strong Generic, Austedo Sales
July 31, 2024
Via
Benzinga
Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-Raise
July 31, 2024
Via
Investor's Business Daily
Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility
July 31, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance
July 31, 2024
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
July 30, 2024
Via
Benzinga
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
July 25, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Why Hims & Hers Heath Shares Are Surging Today
July 22, 2024
Via
Benzinga
Teva's Migraine Treatment Found Effective For Children As Young As 6
July 18, 2024
Via
Benzinga
Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine
July 18, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
July 17, 2024
Via
Benzinga
3 No-Brainer Stocks to Buy With $200 Right Now
July 17, 2024
Via
The Motley Fool
Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
July 16, 2024
Via
Benzinga
Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
July 10, 2024
Via
MarketBeat
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.